Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20781 / DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ondansetron hydrochloride(UNII: NMH84OZK2B) (ondansetron - UNII:4AF302ESOS) | ondansetron hydrochloride | 4mg |
Inactive Ingredients
| Ingredient Name | GlaxoSmithKline LLC | Cardinal Health | Novartis Pharmaceuticals Corporation | REMEDYREPACK INC. |
|---|---|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||||
| ASPARTAME(Z0H242BBR1) | ||||
| FERRIC OXIDE YELLOW(EX438O2MRT) | ||||
| gelatin(2G86QN327L) | ||||
| GELATIN, UNSPECIFIED(2G86QN327L) | ||||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||||
| LACTOSE, UNSPECIFIED FORM(J2B2A4N98G) | ||||
| MAGNESIUM STEARATE(70097M6I30) | ||||
| mannitol(3OWL53L36A) | ||||
| METHYLPARABEN SODIUM(CR6K9C2NHK) | ||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||||
| PROPYLPARABEN SODIUM(625NNB0G9N) | ||||
| SODIUM BENZOATE(OJ245FE5EU) | ||||
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||
| SORBITOL(506T60A25R) | ||||
| STARCH, CORN(O8232NY3SJ) | ||||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||||
| TRIACETIN(XHX3C3X673) | ||||
| WATER(059QF0KO0R) |
